Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-032501·BiomX Inc.
Schedule 13G ownership disclosure
BIOMX INC
Common Stock, $0.0001 par value per share · CUSIP: 09090D103
Event date: 2025-02-27
- Filing-level shares
- 2,494,110
- Percent of class
- 9.99%
- Cystic Fibrosis Foundation
Shares: 2,494,110 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-032501
- Form type
- SCHEDULE 13G/A
- Filer
- BiomX Inc.
- CIK
- CIK 1739174
- Filed
- Mar 04, 2025
- Reporting period
- Feb 27, 2025
- Description
- Schedule 13G beneficial ownership